Aetna and Humana shareholders on Monday voted to approve a merger between the two companies, Modern Healthcare reports.
Aetna in a in a statement said 99% of its voting shares approved the merger, while in a separate statement said 99% its voting shares also approved the deal.
In July, Aetna announced it reached a $37 billion deal to purchase Humana, which could make Aetna the nation’s second-largest insurer. A Kaiser Family Foundation report determined, “If the deal between Aetna and Humana proceeds, the consolidated firm would provide coverage to more than one-quarter — 26% — of all Medicare Advantage enrollees nationwide, making it the leading Medicare Advantage insurer.”
Federal regulators must approve the proposal, and antitrust experts say the Department of Justice and state attorneys general are likely to scrutinize it closely. DOJ is reviewing the deal to determine whether it would “substantially … lessen competition” and thus violate the Clayton Antitrust Act of 1914.
In addition, the deal must meet certain closing conditions. The two insurers expect the deal to be completed by the second half of 2016.
Full content: Modern Healthcare
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI